Left atrial strain on 2D-STE in pediatric dilated cardiomyopathy

Yi Wu1, Qiu-Qin Xu1, Wei Liu2

  • 1Department of Cardiology, Children's Hospital of Soochow University, Zhongnan Street 92, Suzhou, Jiangsu Province, 215025, China.

Insights

Pediatric dilated cardiomyopathy (DCM) patients showed improved left atrial (LA) strain after medical therapy. Left atrial conduit strain (LAScd) may serve as a sensitive indicator for LA strain in pediatric DCM.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Echocardiography

Background:

  • Pediatric dilated cardiomyopathy (DCM) is a serious condition affecting heart function.
  • Left atrial (LA) strain assessment using two-dimensional speckle tracking echocardiography (2D-STE) is crucial for evaluating cardiac health.
  • Understanding LA strain progression in pediatric DCM patients under medical therapy is essential for prognosis.

Purpose of the Study:

  • To characterize left atrial (LA) strain in pediatric dilated cardiomyopathy (DCM) using 2D-STE.
  • To evaluate the progression of LA strain with long-term medical therapy in pediatric DCM patients.
  • To identify potential imaging biomarkers for LA strain in pediatric DCM.

Main Methods:

  • Retrospective review of pediatric DCM patients receiving standardized medical treatment for over one year.
  • Inclusion of age- and sex-matched controls with normal echocardiography.
  • Analysis of echocardiographic images at baseline, 1-year, and >2-year post-treatment using 2D-STE to assess LA strain (LASr, LAScd) and tissue mitral annular displacement (TMAD).

Main Results:

  • Pediatric DCM patients exhibited significantly lower LA reservoir strain (LASr) and conduit strain (LAScd) compared to controls.
  • Patients with DCM associated with left ventricular (LV) hypertrabeculation showed improved LVEF, LVFS, LASr, and LAScd compared to isolated DCM.
  • Significant improvements in LVEF, LVFS, LASr, and LAScd were observed between 1-year and >2-year post-treatment periods.

Conclusions:

  • Long-term standardized medical treatment significantly improves left atrial reservoir and conduit functions in pediatric DCM patients.
  • Left atrial conduit strain (LAScd) demonstrates potential as a sensitive imaging modality for assessing LA strain in pediatric DCM.
  • 2D-STE is a valuable tool for monitoring LA strain progression and treatment response in pediatric DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...